Android app Apple app link

Zevra Therapeutics, Inc. (ZVRA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.73
Day's range
$9.12

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/27/2026 BTIG Kambiz Yazdi $24.00 $9.53   151.97%
07/27/2026 Canaccord Genuity Sumant Kulkarni $20.00 $9.53   109.97%
06/10/2026 Maxim Group Jason McCarthy $35.00 $13.67   156.09%
06/10/2026 Guggenheim Eddie Hickman $29.00 $13.66   112.3%
06/09/2026 Canaccord Genuity Sumant Kulkarni $29.00 $12.09   139.87%
05/08/2026 Guggenheim Eddie Hickman $25.00 $11.00   127.27%
03/10/2026 Guggenheim Eddie Hickman $23.00 $11.03   108.52%
12/30/2025 H.C. Wainwright Brandon Folkes $26.00 $8.82   194.78%
11/06/2025 Cantor Fitzgerald Kristen Kluska $24.00 $9.29   158.48%
02/04/2025 Guggenheim Zevra Therapeutics to $ $21.00 $8.13   158.3%
09/24/2024 Roth Capital Jonathan Aschoff $21.00 $7.58   177.04%
09/24/2024 Maxim Group Jason McCarthy $25.00 $7.58   229.82%
09/23/2024 JMP Securities Jason Butler $17.00 $7.58   124.27%
09/23/2024 H.C. Wainwright Oren Livnat $20.00 $7.92   152.52%
09/18/2024 Canaccord Genuity Sumant Kulkarni $22.00 $7.53   192.16%

Zevra Therapeutics Inc FAQ's

Zevra Therapeutics Inc has been rated by research analysts at Guggenheim, BTIG, Canaccord Genuity, Maxim Group, H.C. Wainwright, Cantor Fitzgerald in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.